These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1305 related articles for article (PubMed ID: 10080844)
41. Environmental risk factors in the development of adenocarcinoma of the oesophagus or gastric cardia: a cross-sectional study in a Dutch cohort. DE Jonge PJ; Wolters LM; Steyerberg EW; VAN Dekken H; Kusters JG; Kuipers EJ; Siersema PD Aliment Pharmacol Ther; 2007 Jul; 26(1):31-9. PubMed ID: 17555419 [TBL] [Abstract][Full Text] [Related]
43. Esophagitis: incidence and risk of esophageal adenocarcinoma--a population-based cohort study. Lassen A; Hallas J; de Muckadell OB Am J Gastroenterol; 2006 Jun; 101(6):1193-9. PubMed ID: 16771936 [TBL] [Abstract][Full Text] [Related]
44. Risk factors, DNA damage, and disease progression in Barrett's esophagus. Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340 [TBL] [Abstract][Full Text] [Related]
45. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156 [TBL] [Abstract][Full Text] [Related]
46. Patient demographics and lifestyle factors influencing long-term survival of oesophageal cancer and gastric cardia cancer in a nationwide study in Sweden. Sundelöf M; Lagergren J; Ye W Eur J Cancer; 2008 Jul; 44(11):1566-71. PubMed ID: 18434132 [TBL] [Abstract][Full Text] [Related]
47. [Strongly increasing incidence of adenocarcinoma of the esophagus and gastric cardia]. Walther C; Zilling T; Perfekt R; Möller T Lakartidningen; 2004 Jan; 101(3):180-3. PubMed ID: 14763086 [TBL] [Abstract][Full Text] [Related]
48. Adenocarcinoma of the oesophagus and gastric cardia: male preponderance in association with obesity. Ryan AM; Rowley SP; Fitzgerald AP; Ravi N; Reynolds JV Eur J Cancer; 2006 May; 42(8):1151-8. PubMed ID: 16630714 [TBL] [Abstract][Full Text] [Related]
49. Population attributable risks of esophageal and gastric cancers. Engel LS; Chow WH; Vaughan TL; Gammon MD; Risch HA; Stanford JL; Schoenberg JB; Mayne ST; Dubrow R; Rotterdam H; West AB; Blaser M; Blot WJ; Gail MH; Fraumeni JF J Natl Cancer Inst; 2003 Sep; 95(18):1404-13. PubMed ID: 13130116 [TBL] [Abstract][Full Text] [Related]
50. Epidemiology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third. Vial M; Grande L; Pera M Recent Results Cancer Res; 2010; 182():1-17. PubMed ID: 20676867 [TBL] [Abstract][Full Text] [Related]
51. Adenocarcinomas of the esophagus and gastric cardia: medical conditions, tobacco, alcohol, and socioeconomic factors. Zhang ZF; Kurtz RC; Sun M; Karpeh M; Yu GP; Gargon N; Fein JS; Georgopoulos SK; Harlap S Cancer Epidemiol Biomarkers Prev; 1996 Oct; 5(10):761-8. PubMed ID: 8896886 [TBL] [Abstract][Full Text] [Related]
52. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Chow WH; Blaser MJ; Blot WJ; Gammon MD; Vaughan TL; Risch HA; Perez-Perez GI; Schoenberg JB; Stanford JL; Rotterdam H; West AB; Fraumeni JF Cancer Res; 1998 Feb; 58(4):588-90. PubMed ID: 9485003 [TBL] [Abstract][Full Text] [Related]
53. Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the esophagus. Sadeghi S; Bain CJ; Pandeya N; Webb PM; Green AC; Whiteman DC; Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1169-78. PubMed ID: 18483339 [TBL] [Abstract][Full Text] [Related]
54. Antioxidants and cancers of the esophagus and gastric cardia. Terry P; Lagergren J; Ye W; Nyrén O; Wolk A Int J Cancer; 2000 Sep; 87(5):750-4. PubMed ID: 10925371 [TBL] [Abstract][Full Text] [Related]
55. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Farrow DC; Vaughan TL; Sweeney C; Gammon MD; Chow WH; Risch HA; Stanford JL; Hansten PD; Mayne ST; Schoenberg JB; Rotterdam H; Ahsan H; West AB; Dubrow R; Fraumeni JF; Blot WJ Cancer Causes Control; 2000 Mar; 11(3):231-8. PubMed ID: 10782657 [TBL] [Abstract][Full Text] [Related]
56. Epidemiology of esophageal adenocarcinoma. Pera M; Manterola C; Vidal O; Grande L J Surg Oncol; 2005 Dec; 92(3):151-9. PubMed ID: 16299786 [TBL] [Abstract][Full Text] [Related]
57. Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Corley DA; Kubo A; Zhao W Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):352-8. PubMed ID: 18268119 [TBL] [Abstract][Full Text] [Related]
58. Adenocarcinoma of the esophagus and gastric cardia: is there progress in the face of increasing cancer incidence? Sampliner RE Ann Intern Med; 1999 Jan; 130(1):67-9. PubMed ID: 9890855 [No Abstract] [Full Text] [Related]
59. Oral disease and risk of oesophageal and gastric cancer in a nationwide nested case-control study in Sweden. Ljung R; Martin L; Lagergren J Eur J Cancer; 2011 Sep; 47(14):2128-32. PubMed ID: 21489778 [TBL] [Abstract][Full Text] [Related]
60. The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Lagergren J; Bergström R; Lindgren A; Nyrén O Int J Cancer; 2000 Feb; 85(3):340-6. PubMed ID: 10652424 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]